Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01078987 · ClinicalTrials.gov registry record · Phase 4
Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF)
A Phase 4 study, sponsored by Loma Linda University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT01078987 is a Phase 4 study that was terminated before completion, run by Loma Linda University. The registered enrollment target is 12 participants.
The verdict
NCT01078987, a Phase 4 study, was terminated before completion, sponsored by Loma Linda University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the pathophysiology of nephrogenic fibrosing dermopathy (NFD)/nephrogenic systemic fibrosis (NSF).
Interventions
- PROCEDURE Plasmapheresis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2002-02 |
| Est. Completion | 2012-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01078987
The ClinicalTrials.gov registry entry for NCT01078987 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Plasmapheresis is the first listed.
NCT01078987 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01078987 about?
NCT01078987 is a clinical study titled "Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF)". The purpose of this study is to evaluate the pathophysiology of nephrogenic fibrosing dermopathy (NFD)/nephrogenic systemic fibrosis (NSF).
What is the current status of trial NCT01078987?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2002-02. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01078987?
The interventions under investigation include: Plasmapheresis (PROCEDURE).
Who is sponsoring clinical trial NCT01078987?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.